
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 80210-62-4 |
| Catalog No. | 2A-9009664 |
| Chinese Name | 头孢泊肟 |
| Synonyms | Cefpodoxime Acid; cefpodoxime; cefpodoxima; U 76253A |
| Molecular Formula | C15H17N5O6S2 |
| Molecular Weight | 427.46 |
| Purity | 98 |
| Density | 1.8±0.1 g/cm3 |
| Melting Point | 200-202ºC |
| Appearance | White to light yellow powder |
| Storage Condition | -20°C, sealed, dry |
| Application | Cefpodoxime (cefpodoxime acid) is an antibiotic effective against both Gram-positive and Gram-negative bacteria. Cefpodoxime inhibits most cells in the microbiota. Cefpodoxime can be used in the study |
| PubChem ID | 329754145 |
| MDL Number | MFCD00864906 |
| SMILES | O=C(/C(C1=CSC(N)=N1)=N\OC)N[C@H](C2=O)[C@]3([H])N2C(C(O)=O)=C(COC)CS3 |
| InChI | 1S/C15H17N5O6S2/c1-25-3-6-4-27-13-9(12(22)20(13)10(6)14(23)24)18-11(21)8(19-26-2)7-5-28-15(16)17-7/h5,9,13H,3-4H2,1-2H3,(H2,16,17)(H,18,21)(H,23,24)/b19-8-/t9-,13-/m1/s1 |
| InChI Key | WYUSVOMTXWRGEK-HBWVYFAYSA-N |
| Beilstein/REAXYS | 6021381 |
| NACRES Code | NA.24 |
| UNSPSC | 41116107 |
| Hazard Symbols | Transport |
| MSDS | msds/9664_1_80210_62_4.pdf |
| Bioactivity | Cefpodoxime (Cefpodoxime acid) is a potent antibiotic active against gram-positive and gram-negative bacteria. Cefpodoxime inhibits the majority of cells in microbial populations. Cefpodoxime can be used for acute otitis media, sinusitis and tosillopharyngitis research[1][2]. Related Catalog Research Areas >> Infection Signaling Pathways >> Anti-infection >> Bacterial In Vitro Cefpodoxime (Cefpodoxime acid) inhibits gram-negative anaerobic rods (Bacteroidaceae) with MIC values of 0.125-4 mg/L. Cefpodoxime inhibits Veillonella parvula with MIC values of 0.25-8 mg/L. Cefpodoxime inhibits Peptostreptococcus micros, Peptostreptococcus asaccharolyticus and Ruminococcus bromii with MIC values of <2 mg/L[1]. Cefpodoxime (Cefpodoxime acid) inhibits bacterial populations of S. pneumoniae and S. pyogenes. cfu[2]. In Vivo Cephalosporins (2.5-50 mg/kg; p.o.; every 8 hours; for 48 hours) have good curative effect in mice[3]. Animal Model: Female Swiss CD1 mice[3] Dosage: 2.5, 5, 10, 25, 40 and 50 mg/kg Administration: Oral administration; every 8 hours; for 48 hours Result: Efficacy was obtained with values of >350. References [1]. Werner H, et, al. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis. Infection. 1991 Sep-Oct;19(5):377-9. [2]. Valentini S, et, al. In-vitro evaluation of cefpodoxime. J Antimicrob Chemother. 1994 Mar;33(3):495-508. [3]. Pérez-Trallero E, et, al. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin. J Chemother. 2001 Apr;13(2):118-25. Chemical & Physical Properties Density 1.8±0.1 g/cm3 Melting Point 200-202ºC Molecular Formula C15H17N5O6S2 Molecular Weight 427.455 Exact Mass 427.062012 PSA 209.98000 LogP 0.94 Index of Refraction 1.780 InChIKey WYUSVOMTXWRGEK-NOZJJQNGSA-N SMILES COCC1=C(C(=O)O)N2C(=O)C(NC(=O)C(=NOC)c3csc(N)n3)C2SC1 |
| Use of | Cefpodoxime (Cefpodoxime acid) is a potent antibiotic active against gram-positive and gram-negative bacteria. Cefpodoxime inhibits the majority of cells in microbial populations. Cefpodoxime can be used for acute otitis media, sinusitis and tosillopharyngitis research[1][2]. Properties Articles15 Name cefpodoxime Synonym More Synonyms cefpodoxime Biological Activity Description Cefpodoxime (Cefpodoxime acid) is a potent antibiotic active against gram-positive and gram-negative bacteria. Cefpodoxime inhibits the majority of cells in microbial populations. Cefpodoxime can be used for acute otitis media, sinusitis and tosillopharyngitis research[1][2]. Related Catalog Research Areas >> Infection Signaling Pathways >> Anti-infection >> Bacterial References [1]. Werner H, et, al. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis. Infection. 1991 Sep-Oct;19(5):377-9. [2]. Valentini S, et, al. In-vitro evaluation of cefpodoxime. J Antimicrob Chemother. 1994 Mar;33(3):495-508. [3]. Pérez-Trallero E, et, al. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin. J Chemother. 2001 Apr;13(2):118-25. Chemical & Physical Properties Molecular Formula C15H17N5O6S2 Exact Mass 427.062012 PSA 209.98000 Index of Refraction 1.780 InChIKey WYUSVOMTXWRGEK-NOZJJQNGSA-N |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available |
| Related Products in Functional Building Blocks | ||
|---|---|---|
| 4-(Trifluoromethyl)-2'-biphenylcarboxylic acid | 84392-17-6 | 2A-9008989 |
| 4-Isobutoxybenzohydrazide | 91430-26-1 | 2A-9008996 |
| Balsalazide | 80573-04-2 | 2A-9009298 |
| Balsalazide disodium dihydrate | 150399-21-6 | 2A-9009299 |
| Cefmenoxime | 65085-01-0 | 2A-9009639 |
| Cefpodoxime proxetil | 87239-81-4 | 2A-9009665 |
| Ceftizoxime | 68401-81-0 | 2A-9009679 |
| Ceftizoxime sodium | 68401-82-1 | 2A-9009680 |
| Chlorothiazide | 58-94-6 | 2A-9009751 |
| Cinoxopazide | 88053-05-8 | 2A-9009812 |
| Browse all Functional Building Blocks products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA